Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-002480-17Phase 3Completed
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Topical tranexamic acid with Placebo (2 arms). Primary endpoint: Estimated blood loss reduction. Started Jul 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-002480-17.